KDKeltouma Driouch

Keltouma Driouch

*This is an algorithmically generated author record based on publicly available information.

Keltouma Driouch has a total of 8 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Gene arrays for diagnosis, prognosis and treatment of breast cancer metastasis

    by Keltouma Driouch, Thomas Landemaine, Soraya Sin, ShaoXiao Wang, Rosette Lidereau

    The advent of microarray tools has generated a massive amount of gene expression data. These data have greatly enhanced our understanding of the biology of breast cancer metastasis and provide a way to improve the prediction of the metastatic potential of breast tumours. Gene-expression profiling has highlighted the molecular heterogeneity of mammary tumours and contributed to the identification of a new molecular classification of breast cancers. In addition, several molecular signatures predicting the likelihood of distant metastases for breast cancer patients have been characterized. Further reports have described gene expression profiles associated with specific metastatic phenotypes, including the organ preference of breast cancer metastasis. Here we review the major studies that had important impacts on the understanding of breast cancer metastasis. We also discuss the future challenges in this research field and the special issues that still need to be examined.


  • Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors

    by Keltouma Driouch, Hans Prydz, Rossana Monese, Henning Johansen, Rosette Lidereau, Eirik Frengen

    The presence of putative tumor-suppressor genes on chromosome 16q23.2-24.1 has been suggested by LOH analysis in several cancer types. This region overlaps with the fragile site FRA16D and the region of homozygous deletions found in several cancer types. The candidate gene WWOX/FOR has been mapped within this region. The mouse homologue of the WWOX protein has been defined as an apoptogenic protein and an essential partner of p53 in cell death, supporting WWOX as a tumor suppressor gene candidate. We performed an expression study of the WWOX/FOR gene in a series of human breast tumors and breast cancer cell lines, and detected reduced expression of the WWOX/FOR transcript in a series of breast cancer cells. Furthermore, identification of two distinct alternative WWOX transcripts expressed at high levels in human tumors suggests an involvement of the WWOX gene in breast cancer progression.